| Literature DB >> 15904528 |
Mitra Zandi1, Mohsen Adib-Hajbagheri, Robabeh Memarian, Anooshiravan Kazem Nejhad, Seyed Moayed Alavian.
Abstract
BACKGROUND: Chronic liver disease especially liver cirrhosis is one of the medical problems that substantially reduces the quality of life of its victims. Because of the chronic and irreversible nature of the disease, it needs self-care programs to be developed according to client's needs and to maintain their independence and sense of well-being. The purpose of this study was to determine the effects of a self-care educational program on Quality of Life (QoL) of a sample of Iranian cirrhotic patients.Entities:
Mesh:
Year: 2005 PMID: 15904528 PMCID: PMC1156929 DOI: 10.1186/1477-7525-3-35
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
The content of four educational sessions
| Session 1 | Nature of the disease | Etiology, transmission route, clinical manifestations, diagnosis, management and complications |
| Session 2 | Coping strategies in systemic symptoms | Fatigue, dry mouth and, pruritus |
| Session 3 | Coping strategies in worry, nutrition | Anxiety, relaxation techniques, diet and nutrition, |
| Session 4 | Muscular cramps, Medical therapies | Medical regimen and its side effects, and relieving factors |
Demographic data of cirrhotic patients in the control and experimental groups
| 46 + 12.5 | 40 + 12.5 | 0.18 | |
| Male | (14), 70 | (10), 50 | 0.19 |
| Female | (6), 30 | (10), 50 | |
| Illiterate | (2), 10 | (6), 30 | 0.27 |
| Primary or secondary school | (6), 30 | (4), 20 | |
| Diploma or higher | (12), 60 | (10), 50 | |
| Single | (2), 10 | (2), 10 | 0.38 |
| Married | (16), 80 | (17), 85 | |
| Divorced | (2), 10 | (1), 5 | |
| Less than or equal to 3 | (14), 70 | (11), 55 | 0.32 |
| More than 3 | (6), 30 | (9), 45 | |
| Laborer | (6), 30 | (8), 40 | 0.32 |
| Employee | (4), 20 | (6), 30 | |
| Housewife | (4), 20 | (4), 20 | |
| Student | (2), 10 | (2), 10 | |
| Retired | (4), 20 | - | |
| 1–3 | (12), 60 | (14), 70 | 0.32 |
| 3–6 | (6), 30 | (4), 20 | |
| More than 6 | (2), 10 | (2), 10 | |
| None | (12), 60 | (8), 40 | 0.41 |
| 1 | (2), 10 | (4), 20 | |
| 3 | (6), 30 | (8), 40 | |
| Hepatitis B | (10), 50 | (9), 45 | 0.83 |
| Hepatitis C | (2), 15 | (4), 20 | |
| Autoimmune disease | (4), 20 | (4), 20 | |
| Cryptogenic | (4), 20 | (4), 20 | |
| A | (4), 20 | (4), 20 | 0.77 |
| B | (8), 40 | (10), 50 | |
| C | (8), 40 | (6), 30 |
Figure 1Mean score of CLDQ in the control and experimental groups before and after intervention
Figure 2Mean score of CLDQ domains in cirrhotic patients in the control group before and after intervention
Figure 3Mean score of CLDQ domains in cirrhotic patients in the experimental group before and after the intervention